| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |